Saccharomyces cerevisiae as a model system to study the response to anticancer agents Renata MatuoFabrício G. SousaJoão Antonio Pêgas Henriques Review Article 01 August 2012 Pages: 491 - 502
A phase 1 study of vinflunine in combination with trastuzumab for the treatment for HER2-positive metastatic breast cancer R. ParidaensO. RixeH. Roche Original Article 04 August 2012 Pages: 503 - 511
Characterizing the disposition, metabolism, and excretion of an orally active pan-deacetylase inhibitor, panobinostat, via trace radiolabeled 14C material in advanced cancer patients Sally CliveMargaret M. WooMark Kagan Original Article 05 August 2012 Pages: 513 - 522
Safety and feasibility of adjuvant chemotherapy with S-1 for Korean patients with curatively resected advanced gastric cancer Jae Ho JeongMin-Hee RyuYoon-Koo Kang Original Article 05 August 2012 Pages: 523 - 529
A phase II study of docetaxel plus nedaplatin in patients with metastatic non-small-cell lung cancer Koji TeramotoYoshikuni AsadaShozo Fujino Original Article 05 August 2012 Pages: 531 - 537
The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma Han Sang KimHye Ryun KimByoung Chul Cho Original Article 07 August 2012 Pages: 539 - 546
Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors Joanna M. BrellSmitha S. KrishnamurthiAfshin Dowlati Original Article 07 August 2012 Pages: 547 - 553
The relationship between Helicobacter pylori infection and the effects of chemotherapy in patients with advanced or metastatic gastric cancer In Keun ChoiHwa Jung SungJae Hong Seo Original Article 08 August 2012 Pages: 555 - 558
A phase I study of BMS-690514 in Japanese patients with advanced or metastatic solid tumors Hiroshi NokiharaNoboru YamamotoTomohide Tamura Original Article Open access 10 August 2012 Pages: 559 - 565
A single supratherapeutic dose of ridaforolimus does not prolong the QTc interval in patients with advanced cancer Richard M. LushAmita PatnaikAnthony Tolcher Original Article Open access 10 August 2012 Pages: 567 - 574
The efficacy and safety of bevacizumab beyond first progression in patients treated with first-line mFOLFOX6 followed by second-line FOLFIRI in advanced colorectal cancer: a multicenter, single-arm, phase II trial (CCOG-0801) Goro NakayamaKeisuke UeharaYasuhiro Kodera Original Article Open access 12 August 2012 Pages: 575 - 581
A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy Yeul Hong KimKei MuroChung-Pin Li Original Article Open access 12 August 2012 Pages: 583 - 590
A population pharmacokinetic/pharmacodynamic model of thrombocytopenia characterizing the effect of trastuzumab emtansine (T-DM1) on platelet counts in patients with HER2-positive metastatic breast cancer Brendan C. BenderFranziska Schaedeli-StarkManish Gupta Original Article 12 August 2012 Pages: 591 - 601
Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases Raffaele AddeoPasquale SperlonganoMichele Caraglia Original Article 14 August 2012 Pages: 603 - 609
Open-label, single-arm phase II study of pemetrexed in the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma who have had prior platinum-based chemotherapy Yang ZhangLiping ZhaoLi Zhang Original Article 19 August 2012 Pages: 611 - 615
Single-dose pharmacokinetic and toxicity analysis of pyrrole–imidazole polyamides in mice Timothy W. SynoldBixin XiPeter B. Dervan Original Article Open access 21 August 2012 Pages: 617 - 625
